Picture of Cyxone AB logo

CYXO — Cyxone AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Cyxone Receives Intention To Grant From EPO

Oct 9 (Reuters) - Cyxone AB  CYXO.ST :
    * RECEIVES INTENTION TO GRANT FROM THE EUROPEAN PATENT
OFFICE FOR
A UNITARY PATENT OF T20K
    * PATENT COVERS PROTECTION OF DRUG CANDIDATE T20K THAT
CYXONE
LICENSES FROM MEDICAL UNIVERSITY OF VIENNA AND UNIVERSITY OF
FREIBURG
    * WHEN APPROVED, PATENT WILL BE VALID UNTIL 2032

Source text for Eikon:  ID:nWkr81zfNf 
Further company coverage:  CYXO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Cyxone AB

See all news